HIGHLIGHTS
- who: Béatrice Riteau from the Tours, France University of Tübingen, Germany have published the Article: FPR2: A Novel Promising Target for the Treatment of Influenza, in the Journal: (JOURNAL)
- what: Preclinical studies have proven that FPR2 antagonists efficiently protect mice against IAV infections, by inhibiting viral_replication September 2017 | Volume 8 | Article 1719 FPR2 as Anti-influenza Target
SUMMARY
H7N9 and H5N1 viruses can be transmitted from the avian reservoir directly to humans but do not spread between humans (Imai et_al, 2013; Richard et_al, 2013). Although host-directed antivirals are . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.